Although some human melanomas may signal primarily via PI3K/Akt instead of MAPK signaling, loss of the tumor suppressor PTEN can lead to MAPK pathway activation via translocation of β-catenin to the nucleus, where it acts to regulate MITF transcription and promote metastasis independently of PI3K/Akt signaling [80]. This evidence concerns the gene MITF and melanoma.